AC IMMUNE SA SF-02 (IMR) — Cash Flow Reinvestment Rate
AC IMMUNE SA SF-02 (IMR) has a Cash Flow Reinvestment Rate of 0.64x as of December 2024, reinvesting €3.83 Million (capex €90.00K plus investments €-3.74 Million) from operating cash flow of €5.93 Million. See AC IMMUNE SA SF-02 free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AC IMMUNE SA SF-02 Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for AC IMMUNE SA SF-02 across 1 annual periods. For the full cash flow conversion analysis, see IMR cash generation efficiency.
Annual Cash Flow Reinvestment Rate for AC IMMUNE SA SF-02 (2024–2024)
Year-by-year capital reinvestment analysis for AC IMMUNE SA SF-02. See AC IMMUNE SA SF-02 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.60x | €105.24 Million | €65.84 Million | €576.00K | — |